SCHEMBL19132181

SCHEMBL19132181

Fc1ccc(-c2cnc(-c3ccccc3)o2)c(F)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.56
TSHR P16473 1/20 0.56
CASP1 P29466 1/20 0.56
RAB9A P51151 6/20 0.49
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
MITF O75030 1/20 0.49
CREBBP Q92793 2/20 0.48
NPC1 O15118 5/20 0.45
KDM4E B2RXH2 5/20 0.45
ALDH1A1 P00352 5/20 0.45
HPGD P15428 4/20 0.45
HSD17B10 Q99714 3/20 0.45
PTPN1 P18031 4/20 0.45
ATM Q13315 1/20 0.44
SMN1; SMN2 Q16637 3/20 0.43
CYP1A2 P05177 2/20 0.43
CYP2C9 P11712 2/20 0.43
CYP2C19 P33261 2/20 0.43
TP53 P04637 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1505182 0.84 MAP4K4 (0.48) ALOX15TSHRCASP1RAB9AMEN1
SCHEMBL12171800 0.83 MAOA (0.46) RAB9AMEN1KMT2ANPC1KDM4E
SCHEMBL12797830 0.81 SLC9A1 (0.42) RAB9AMEN1KMT2ANPC1KDM4E
SCHEMBL3251579 0.79 PIK3R1 (0.48) ALOX15RAB9AMEN1KMT2ANPC1
SCHEMBL29231870 0.79 ALOX15 (0.82) ALOX15TSHRCASP1RAB9AMEN1
SCHEMBL3253548 0.77 RAB9A (0.67) TSHRRAB9AMEN1KMT2ANPC1
SCHEMBL1505233 0.77 MAPT (0.59) RAB9ANPC1KDM4EALDH1A1HPGD
SCHEMBL4343347 0.75 ALOX15 (0.69) ALOX15TSHRCASP1RAB9AMEN1
SCHEMBL14638109 0.74 MGAM (0.41) RAB9ANPC1GAABCHEACHE
SCHEMBL74359 0.74 ALOX15 (0.96) ALOX15TSHRCASP1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170204073-A1 COMPOUNDS FOR NONSENSE SUPPRESSION, AND METHODS FOR THEIR USE PTC THERAPEUTICS, INC. (US) 2017-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170204073-A1 COMPOUNDS FOR NONSENSE SUPPRESSION, AND METHODS FOR THEIR USE NSUN2, UPF1, NSUN3 ALOX15 2616/4885TSHR 3714/4885CASP1 4172/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.